USD 115.66
Price
-0.06
(-0.05%)
Day Change
|
|
---|
NVS, the overall quality is good (Quality = 77) and the timing to buy is ...(Sign In to See)...
- Signal
- OUTPERFORM
- Signal Description
- Company financial health is Good
- Reason
-
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Current growth of ROA was below our criteria.
In details, quality factors are not quite good , financial health is not quite good , and ability to make profit is very good , ...
Quality Factors |
|
54% |
In Recommendations? | Not in any sections |
Select Rate | 0.00 From 30 days period |
Watch Rate | 0.05 From 30 days period |
Social Score | 2 |
Magic Formula Rank by ROA |
682
|
Magic Formula Rank by ROE |
682
|
Magic Formula Rank by ROIC |
1230
|
Price | 115.66 |
PBV / Sector |
5.61 / 17.03
|
Earning Per Share | 4.89 |
PE / Sector |
23.66 / 42.76
|
PEG or PE/Growth / Sector |
4.19 / 1.58
|
Average 1M Daily Value |
125.25 M
GREAT
|
Average 1W Daily Value |
159.95 M
GREAT
|
Timing Factors |
|
57% |
Financial Health |
|
56% |
Ability to Make Profit |
|
81% |
Return to Investors |
|
33% |
Registration Details |
Analyze Date | 2024-09-14 18:48:56 |
Symbol | NVS |
Name | NOVARTIS AG ADR |
Sector | Healthcare >> Drug Manufacturers - General |
Market | NYSE |
Listed Shares | 2,024.58 M |
Par Value | N/A |
Calculated From | Quarter |
Sign | N/A |
Market Cap (M.USD) / Sector Average | 234,284.40 / 223,367.13 |
News, Concensus, ... |
Estimation Consensus | See at WSJ.com |
Full details | See at WSJ.com |
Chart | See in Chart feature |
News | See at Yahoo Finance |